The University of Virginia seeks adults ages 18 and over with histologically proven primary high risk leiomyosarcoma (LMS) or Liposarcoma (LPS) of retroperitoneal space or infra-peritoneal spaces of pelvis.
You will be randomized (assigned by chance) to the standard arm or the experimental arm.
• Standard arm: You will have surgery within 4 weeks following randomization
• Experimental arm: You will undergo 3 cycles of neoadjuvant (before surgery) chemotherapy starting within 2 weeks follow randomization
This study involves blood draw, physical examination, electrocardiogram (ECG), Computed Tomography (CT) scans, and surgery to remove your tumor.
Study-related procedures that are being done beyond your standard of care will be provided at no cost to you or your insurance.
Additional information can be found here: Study Details | Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma | ClinicalTrials.gov
No Compensation